• PDF: Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
  • PRINT/CD-ROM: Despatched within 2 to 4 working days.

Analyzing the Global Market for Active Pharmaceutical Ingredients

  • Publication Date:October 2013
  • Publisher:Aruvian's R'search
  • Product Type: Report
  • Pages:365
  • ISBN:1834180

Analyzing the Global Market for Active Pharmaceutical Ingredients

The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the year 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market.

The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market.

Aruvian Research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expiries of blockbuster drugs and the impact of the economic recession on the market.

An analysis of the market for APIs in Asia Pacific is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Asia Pacific and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan and South Korea.


An analysis of the market for APIs in Europe is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, Spain and the United Kingdom.


An analysis of the market for APIs in North America is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in North America and the impacts on the industry. Key markets analyzed in North America include Canada and the United States.

An analysis of the major industry players such as Teva, Albemarle, Actavis, Boehringer, Cipla and others are included in this in-depth report on the global market for Active Pharmaceutical Ingredients.

A. Executive Summary

B. Introduction to Active Pharmaceutical Ingredients

C. Global Market for Active Pharmaceutical Ingredients (APIs)
C.1 Industry Overview
C.2 Industry Revenues
C.3 Industry Segmentation
C.3.1 Biotech API Market
C.3.2 Synthetic API Market
C.4 Brief Profile: High Potency Active Pharmaceutical Ingredients (HPAPIs)

D. Impacts on the Global API Market
D.1 Impact of the Economic Recession
D.2 Impact of Patent Expiries & Growing Uptake of Biologics
D.3 Increased Price Competition & Price Cuts by Governments
D.4 Growing Number of Mergers & Acquisitions & Increased Global Coverage
D.5 Regulatory Framework

E. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific
E.1 Industry Overview
E.2 Industry Revenues
E.3 Industry Segmentation
E.3.1 Biotech API Market
E.3.2 Synthetic API Market
E.4 Therapeutic Applications of API in Asia Pacific
E.5 Impacts on the Industry

F. Market for Active Pharmaceutical Ingredients (APIs) in China
F.1 Industry Overview
F.2 Industry Revenues
F.3 Industry Segmentation
F.3.1 Biotech API Market
F.3.2 Synthetic API Market

G. Market for Active Pharmaceutical Ingredients (APIs) in India
G.1 Industry Overview
G.2 Industry Revenues
G.3 Industry Segmentation
G.3.1 Biotech API Market
G.3.2 Synthetic API Market

H. Market for Active Pharmaceutical Ingredients (APIs) in Japan
H.1 Industry Overview
H.2 Industry Revenues
H.3 Industry Segmentation
H.3.1 Biotech API Market
H.3.2 Synthetic API Market

I. Market for Active Pharmaceutical Ingredients (APIs) in South Korea
I.1 Industry Overview
I.2 Industry Revenues
I.3 Industry Segmentation
I.3.1 Biotech API Market
I.3.2 Synthetic API Market

J. Market for Active Pharmaceutical Ingredients (APIs) in Europe
J.1 Industry Overview
J.2 Industry Revenues
J.3 Industry Segmentation
J.3.1 Biotech API Market
J.3.2 Synthetic API Market
J.4 Therapeutic Applications of API in Europe
J.5 Impacts on the Industry

K. Market for Active Pharmaceutical Ingredients (APIs) in France
K.1 Industry Overview
K.2 Industry Revenues
K.3 Industry Segmentation
K.3.1 Biotech API Market
K.3.2 Synthetic API Market

L. Market for Active Pharmaceutical Ingredients (APIs) in Germany
L.1 Industry Overview
L.2 Industry Revenues
L.3 Industry Segmentation
L.3.1 Biotech API Market
L.3.2 Synthetic API Market

M. Market for Active Pharmaceutical Ingredients (APIs) in Italy
M.1 Industry Overview
M.2 Industry Revenues
M.3 Industry Segmentation
M.3.1 Biotech API Market
M.3.2 Synthetic API Market

N. Market for Active Pharmaceutical Ingredients (APIs) in Spain
N.1 Industry Overview
N.2 Industry Revenues
N.3 Industry Segmentation
N.3.1 Biotech API Market
N.3.2 Synthetic API Market

O. Market for Active Pharmaceutical Ingredients (APIs) in United Kingdom
O.1 Industry Overview
O.2 Industry Revenues
O.3 Industry Segmentation
O.3.1 Biotech API Market
O.3.2 Synthetic API Market

P. Market for Active Pharmaceutical Ingredients (APIs) in North America
P.1 Industry Overview
P.2 Industry Revenues
P.3 Industry Segmentation
P.3.1 Biotech API Market
P.3.2 Synthetic API Market
P.4 Therapeutic Applications of API in North America
P.5 Impacts on the Industry

Q. Market for Active Pharmaceutical Ingredients (APIs) in Canada
Q.1 Industry Overview
Q.2 Industry Revenues
Q.3 Industry Segmentation
Q.3.1 Biotech API Market
Q.3.2 Synthetic API Market

R. Market for Active Pharmaceutical Ingredients (APIs) in the US
R.1 Industry Overview
R.2 Industry Revenues
R.3 Industry Segmentation
R.3.1 Biotech API Market
R.3.2 Synthetic API Market

S. Major Industry Players
S.1 Albemarle Corporation
S.2 Actavis Plc
S.3 Ampac Fine Chemicals LLC
S.4 Aptuit, Inc
S.5 Aurobindo Pharma
S.6 BASF SE
S.7 Biocon Ltd
S.8 Boehringer Ingelheim GmbH
S.9 Bristol-Myers Squibb Company
S.10 Cambrex Corporation
S.11 Cipla Ltd
S.12 Covidien Plc
S.13 Daiichi Fine Chemical Co., Ltd.
S.14 Dishman Pharmaceuticals & Chemicals Ltd.
S.15 Dr. Reddy's Laboratories Limited
S.16 Fabbrica Italiana Sintetici
S.17 Hospira Inc
S.18 Koninklijke DSM N.V.
S.19 Lonza Group AG
S.20 Lupin Limited
S.21 Matrix Laboratories Limited/Mylan Inc
S.22 Novartis AG
S.23 Novasep Holding
S.24 Pfizer Inc
S.25 Ranbaxy Laboratories
S.26 Sandoz International GmbH
S.27 Sigma-Aldrich Corporation
S.28 Sun Pharmaceutical Industries Limited
S.29 Teva Pharmaceutical Industries Limited
S.30 WuXi AppTec, Inc

T. Glossary of Terms



List of Figures

Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018
Figure 2: Global API Industry Segmentation by Revenues (%), 2012
Figure 3: Revenues of the Global Biotech API Market (in USD Million), 2006-2018
Figure 4: Share of the Global Biotech API Market by Regions (%), 2012
Figure 5: Share of Revenues of the Global Biotech API Market by Regions (%), 2006-2018
Figure 6: Share of the Global Biotech API Market by Application Sector (%), 2012
Figure 7: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2006-2018
Figure 8: Revenues of the Global Synthetic API Market (in USD Million), 2006-2018
Figure 9: Share of the Global Synthetic API Market by Regions (%), 2012
Figure 10: Share of Revenues of the Global Synthetic API Market by Regions (%), 2006-2018
Figure 11: Share of the Global Synthetic API Market by Application Sector (%), 2012
Figure 12: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2006-2018
Figure 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2006-2018
Figure 14: Asia Pacific API Industry Segmentation by Revenues (%), 2012
Figure 15: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2006-2018
Figure 16: Share of the Biotech API Market in Asia Pacific by Countries (%), 2012
Figure 17: Performance & Growth of the Biotech API Market in Asia Pacific (%), 2006-2018
Figure 18: Share of Revenues of the Biotech API Market in Asia Pacific by Countries (%), 2006-2018
Figure 19: Share of the Biotech API Market in Asia Pacific by Application Sector (%), 2012
Figure 20: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018
Figure 21: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2006-2018
Figure 22: Share of the Synthetic API Market in Asia Pacific by Countries (%), 2012
Figure 23: Performance & Growth of the Synthetic API Market in Asia Pacific (%), 2006-2018
Figure 24: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (%), 2006-2018
Figure 25: Share of the Synthetic API Market in Asia Pacific by Application Sector (%), 2012
Figure 26: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018
Figure 27: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2012 & 2018
Figure 28: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2006-2018
Figure 29: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2006-2018
Figure 30: Share of China Biotech API Market by Application Sector (%), 2012
Figure 31: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2006-2018
Figure 32: Share of the Synthetic API Market in China by Application Sector (%), 2006-2018
Figure 33: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2006-2018
Figure 34: India API Industry Segmentation by Revenues (%), 2006-2018
Figure 35: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2006-2018
Figure 36: Share of the Biotech API Market in India by Application Sector (%), 2006-2018
Figure 37: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2006-2018
Figure 38: Share of the Synthetic API Market in India by Application Sector (%), 2006-2018
Figure 39: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2006-2018
Figure 40: Product Type & Revenue Share of the API Market in Japan (%), 2006-2018
Figure 41: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2006-2018
Figure 42: Share of the Biotech API Market in Japan by Application Sector (%), 2006-2018
Figure 43: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2006-2018
Figure 44: Share of the Synthetic API Market in Japan by Application Sector (%), 2006-2018
Figure 45: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2006-2018
Figure 46: South Korea API Industry Segmentation by Revenues (%), 2012
Figure 47: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2006-2018
Figure 48: Share of the South Korea Biotech API Market by Application Sector (%), 2006-2018
Figure 49: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2006-2018
Figure 50: Share of the Synthetic API Market in South Korea by Application Sector (%), 2006-2018
Figure 51: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018
Figure 52: European API Industry Segmentation by Revenues (%), 2012
Figure 53: Revenues of the European Biotech API Market (in USD Million), 2006-2018
Figure 54: Share of the European Biotech API Market by Countries (%), 2012
Figure 55: Performance & Growth of the Biotech API Market in Europe (%), 2006-2018
Figure 56: Share of Revenues of the European Biotech API Market by Countries (%), 2006-2018
Figure 57: Share of the European Biotech API Market by Application Sector (%), 2012
Figure 58: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2006-2018
Figure 59: Revenues of the European Synthetic API Market (in USD Million), 2006-2018
Figure 60: Share of the European Synthetic API Market by Countries (%), 2012
Figure 61: Performance & Growth of the Synthetic API Market in Europe (%), 2006-2018
Figure 62: Share of Revenues of the Europe Synthetic API Market by Countries (%), 2006-2018
Figure 63: Share of the European Synthetic API Market by Application Sector (%), 2012
Figure 64: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2006-2018
Figure 65: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2012 & 2018
Figure 66: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2006-2018
Figure 67: France API Industry Segmentation by Revenues (%), 2006-2018
Figure 68: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2006-2018
Figure 69: Share of the Biotech API Market in France by Application Sector (%), 2006-2018
Figure 70: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2006-2018
Figure 71: Share of the Synthetic API Market in France by Application Sector (%), 2006-2018
Figure 72: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2006-2018
Figure 73: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2006-2018
Figure 74: Share of the Biotech API Market in Germany by Application Sector (%), 2006-2018
Figure 75: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2006-2018
Figure 76: Share of the Synthetic API Market in Germany by Application Sector (%), 2006-2018
Figure 77: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2006-2018
Figure 78: Italy API Industry Segmentation by Revenues (%), 2006-2018
Figure 79: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2006-2018
Figure 80: Share of the Biotech API Market in Italy by Application Sector (%), 2006-2018
Figure 81: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2006-2018
Figure 82: Share of the Synthetic API Market in Italy by Application Sector (%), 2006-2018
Figure 83: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2006-2018
Figure 84: Spain API Industry Segmentation by Revenues (%), 2006-2018
Figure 85: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2006-2018
Figure 86: Share of the Biotech API Market in Spain by Application Sector (%), 2006-2018
Figure 87: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2006-2018
Figure 88: Share of the Synthetic API Market in Spain by Application Sector (%), 2006-2018
Figure 89: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2006-2018
Figure 90: UK API Industry Segmentation by Revenues (%), 2006-2018
Figure 91: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2006-2018
Figure 92: Share of the Biotech API Market in UK by Application Sector (%), 2006-2018
Figure 93: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2006-2018
Figure 94: Share of the Synthetic API Market in UK by Application Sector (%), 2006-2018
Figure 95: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2006-2018
Figure 96: Industry Segmentation of the Active Pharmaceutical Ingredients (API) Market in North America by Revenues (%), 2006-2018
Figure 97: Revenues of the Biotech API Market in North America (in USD Million), 2006-2018
Figure 98: Share of the Biotech API Market in North America by Countries (%), 2012
Figure 99: Performance & Growth of the Biotech API Market in North America (%), 2006-2018
Figure 100: Share of Revenues of the Biotech API Market in North America by Countries (%), 2006-2018
Figure 101: Share of the Biotech API Market in North America by Application Sector (%), 2012
Figure 102: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2006-2018
Figure 103: Revenues of the Synthetic API Market in North America (in USD Million), 2006-2018
Figure 104: Share of the Synthetic API Market in North America by Countries (%), 2012
Figure 105: Performance & Growth of the Synthetic API Market in North America (%), 2006-2018
Figure 106: Share of Revenues by Countries in North America Synthetic API Industry (%), 2006-2018
Figure 107: Share of the Synthetic API Market in North America by Application Sector (%), 2012
Figure 108: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2006-2018
Figure 109: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2012 & 2018
Figure 110: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2006-2018
Figure 111: Revenue Share of the API Market in Canada by Industry Segments (%), 2006-2018
Figure 112: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2006-2018
Figure 113: Share of the Canada Biotech API Market by Application Sector (%), 2006-2018
Figure 114: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2006-2018
Figure 115: Share of the Canada Synthetic API Market by Application Sector (%), 2006-2018
Figure 116: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2006-2018
Figure 117: Revenue Share of the API Market in the US by Industry Segments (%), 2006-2018
Figure 118: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2006-2018
Figure 119: Share of the US Biotech API Market by Application Sector (%), 2006-2018
Figure 120: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2006-2018
Figure 121: Share of the US Synthetic API Market by Application Sector (%), 2006-2018

List of Tables

Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018
Table 2: Revenues of the Global Biotech API Market (in USD Million), 2006-2018
Table 3: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2006-2018
Table 4: Revenues of the Global Synthetic API Market (in USD Million), 2006-2018
Table 5: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2006-2018
Table 6: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2006-2018
Table 7: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2006-2018
Table 8: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018
Table 9: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2006-2018
Table 10: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018
Table 11: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2012 & 2018
Table 34: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2006-2018
Table 35: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2006-2018
Table 36: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2006-2018
Table 37: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2006-2018
Table 38: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2006-2018
Table 39: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2006-2018
Table 40: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2006-2018
Table 41: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2006-2018
Table 42: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2006-2018
Table 43: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2006-2018
Table 44: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2006-2018
Table 45: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2006-2018
Table 12: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018
Table 13: Revenues of the European Biotech API Market (in USD Million), 2006-2018
Table 14: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2006-2018
Table 15: Revenues of the European Synthetic API Market (in USD Million), 2006-2018
Table 16: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2006-2018
Table 17: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2012 & 2018
Table 18: Pricing & Reimbursement Mechanism in Top Markets in Europe, 2012
Table 19: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2006-2018
Table 20: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2006-2018
Table 21: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2006-2018
Table 22: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2006-2018
Table 23: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2006-2018
Table 24: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2006-2018
Table 25: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2006-2018
Table 26: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2006-2018
Table 27: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2006-2018
Table 28: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2006-2018
Table 29: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2006-2018
Table 30: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2006-2018
Table 31: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2006-2018
Table 32: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2006-2018
Table 33: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2006-2018
Table 46: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2006-2018
Table 47: Revenues of the Biotech API Market in North America (in USD Million), 2006-2018
Table 48: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2006-2018
Table 49: Revenues of the Synthetic API Market in North America (in USD Million), 2006-2018
Table 50: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2006-2018
Table 51: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2012 & 2018
Table 52: Drugs with Patent Expiries till 2017
Table 53: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2006-2018
Table 54: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2006-2018
Table 55: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2006-2018
Table 56: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2006-2018
Table 57: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2006-2018
Table 58: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2006-2018




Companies Mentioned

Albemarle Corporation
Actavis Plc
Ampac Fine Chemicals LLC
Aptuit, Inc
Aurobindo Pharma
BASF SE
Biocon Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Cambrex Corporation
Cipla Ltd
Covidien Plc
Daiichi Fine Chemical Co., Ltd.
Dishman Pharmaceuticals & Chemicals Ltd.
Dr. Reddy's Laboratories Limited
Fabbrica Italiana Sintetici
Hospira Inc
Koninklijke DSM N.V.
Lonza Group AG
Lupin Limited
Matrix Laboratories Limited/Mylan Inc
Novartis AG
Novasep Holding
Pfizer Inc
Ranbaxy Laboratories
Sandoz International GmbH
Sigma-Aldrich Corporation
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited
WuXi AppTec, Inc
+44 20 8816 8548

Ask a question about Analyzing the Global Market for Active Pharmaceutical Ingredients

Enter the characters you see in the picture below
Captcha